Pathology of in-stent restenosis.

The process of in-stent restenosis parallels wound healing responses. Stent deployment results in early thrombus deposition and acute inflammation, granulation tissue development, and ultimately smooth muscle cell proliferation and extracellular matrix synthesis. The severity of arterial injury during stent placement correlates with increased inflammation and late neointimal growth. These pathological findings provide useful targets for therapies aimed at reducing the incidence of in-stent restenosis.

[1]  R. Califf,et al.  Complementary clinical benefits of coronary-artery stenting and blockade of platelet glycoprotein IIb/IIIa receptors. Evaluation of Platelet IIb/IIIa Inhibition in Stenting Investigators. , 1999, The New England journal of medicine.

[2]  R. Virmani,et al.  Pathology of bailout coronary stenting in human beings. , 1999, American heart journal.

[3]  E. Nabel.  Delivering genes to the heart—right where it counts! , 1999, Nature Medicine.

[4]  R. Virmani,et al.  Pathology of acute and chronic coronary stenting in humans. , 1999, Circulation.

[5]  E J Topol,et al.  Artery size, neointima, and remodeling: time for some standards. , 1998, Journal of the American College of Cardiology.

[6]  E. Topol,et al.  Frontiers in interventional cardiology. , 1998, Circulation.

[7]  A. Lincoff.  Trials of platelet glycoprotein IIb/IIIa receptor antagonists during percutaneous coronary revascularization. , 1998, The American journal of cardiology.

[8]  R. Virmani,et al.  The stent decade: 1987 to 1997. Stanford Stent Summit faculty. , 1998, American heart journal.

[9]  E. Edelman,et al.  A mAb to the beta2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[10]  S. Lord,et al.  Role of β1 and β3 Integrins in Human Smooth Muscle Cell Adhesion to and Contraction of Fibrin Clots In Vitro , 1998 .

[11]  A. Becker,et al.  Neointimal tissue response at sites of coronary stenting in humans: macroscopic, histological, and immunohistochemical analyses. , 1998, Circulation.

[12]  R. Virmani,et al.  Progressive vascular remodeling and reduced neointimal formation after placement of a thermoelastic self-expanding nitinol stent in an experimental model. , 1998, Catheterization and cardiovascular diagnosis.

[13]  R. Schwartz,et al.  Pathophysiology of restenosis: interaction of thrombosis, hyperplasia, and/or remodeling. , 1998, The American journal of cardiology.

[14]  David P Miller,et al.  Abciximab therapy and unplanned coronary stent deployment: favorable effects on stent use, clinical outcomes, and bleeding complications. EPILOG Trial Investigators. , 1998, Circulation.

[15]  E. Nabel,et al.  Expression of cyclin-dependent kinase inhibitors in vascular disease. , 1998, Circulation research.

[16]  K. March,et al.  Gene therapy for restenosis: getting nearer the heart of the matter. , 1998, Circulation research.

[17]  D. Dichek,et al.  Gene therapy for restenosis: are we ready? , 1998, Circulation research.

[18]  C. Rogers.  A monoclonal antibody to the b2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits , 1998 .

[19]  A. Kastrati,et al.  Bimodal distribution of angiographic measures of restenosis six months after coronary stent placement. , 1997, Circulation.

[20]  J. Wilcox,et al.  Contribution of Adventitial Myofibroblasts to Vascular Remodeling and Lesion Formation after Experimental Angioplasty in Pig Coronary Arteries a , 1997, Annals of the New York Academy of Sciences.

[21]  E. Nabel,et al.  In Vivo Gene Transfer: A Biological Tool , 1997, Annals of the New York Academy of Sciences.

[22]  M. Leon,et al.  Contribution of inadequate arterial remodeling to the development of focal coronary artery stenoses. An intravascular ultrasound study. , 1997, Circulation.

[23]  R. Virmani,et al.  Effects of endovascular radiation from a beta-particle-emitting stent in a porcine coronary restenosis model. A dose-response study. , 1996, Circulation.

[24]  D. Clemmons,et al.  Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Alpers,et al.  αvβ3 Integrin Expression in Normal and Atherosclerotic Artery , 1995 .

[26]  R. Virmani,et al.  Proliferative activity in coronary atherectomy tissue. Clinical, histopathologic, and immunohistochemical correlates. , 1995, Chest.

[27]  S M Schwartz,et al.  The intima. Soil for atherosclerosis and restenosis. , 1995, Circulation research.

[28]  W. Kubler,et al.  Influence of surface texture and charge on the biocompatibility of endovascular stents , 1995, Coronary artery disease.

[29]  E. Edelman,et al.  Endovascular stent design dictates experimental restenosis and thrombosis. , 1995, Circulation.

[30]  A. Kastrati,et al.  Four‐Year Experience With Palmaz‐Schatz Stenting in Coronary Angioplasty Complicated by Dissection With Threatened or Present Vessel Closure , 1994, Circulation.

[31]  R. Virmani,et al.  Morphologic characteristics of lesion formation and time course of smooth muscle cell proliferation in a porcine proliferative restenosis model. , 1994, Journal of the American College of Cardiology.

[32]  P G Anderson,et al.  Long-term histologic patency after percutaneous transluminal coronary angioplasty is predicted by the creation of a greater lumen area. , 1994, Journal of the American College of Cardiology.

[33]  E J Topol,et al.  Local drug delivery for the prevention of restenosis. Fact, fancy, and future. , 1994, Circulation.

[34]  A. Kastrati,et al.  Emergency coronary stenting for dissection during percutaneous transluminal coronary angioplasty: angiographic follow-up after stenting and after repeat angioplasty of the stented segment. , 1994, Journal of the American College of Cardiology.

[35]  K. Bailey,et al.  Differential neointimal response to coronary artery injury in pigs and dogs. Implications for restenosis models. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[36]  R. Virmani,et al.  Coronary angioplasty from the perspective of atherosclerotic plaque: morphologic predictors of immediate success and restenosis. , 1994, American heart journal.

[37]  M. Ferguson,et al.  Proliferation in primary and restenotic coronary atherectomy tissue. Implications for antiproliferative therapy. , 1993, Circulation research.

[38]  B. Binder,et al.  Factors Contributing to Increased Vascular Fibrinolytic Activity in Mongrel Dogs , 1993, Circulation.

[39]  P. Serruys,et al.  Histology after stenting of human saphenous vein bypass grafts: observations from surgically excised grafts 3 to 320 days after stent implantation. , 1993, Journal of the American College of Cardiology.

[40]  W. Baxley,et al.  Vascular pathology of balloon-expandable flexible coil stents in humans. , 1992, Journal of the American College of Cardiology.

[41]  M. Fishbein,et al.  A paradigm for restenosis based on cell biology: clues for the development of new preventive therapies. , 1991, Journal of the American College of Cardiology.